Xcout Intel
LabGenius
LabGenius Ltd is a biotechnology company (also known as LabGenius Therapeutics) that utilizes machine learning and automation to discover and develop novel protein therapeutics. The company collaborates with major pharmaceutical partners, such as LG Chem, to advance research and development activities.
Subscribe to see LabGenius’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
LabGenius at a glance
LabGenius is a biotech company headquartered in United Kingdom, founded in 2012. It has raised at least $47.2M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $44.5M in May 2024. Xcout tracks 18 named people at LabGenius, including Angus Sinclair (Chief Scientific Officer).
LabGenius leadership
- Angus SinclairChief Scientific Officer
- Hannah SeitzChief Business Officer
- Edwin MosesChairman
- James FieldChief Executive Officer
- Catherine HowshamVP, Projects and Portfolio Delivery
- Edward de MoravilleVP, Finance
12 more named people on record for LabGenius, with roles, board committees and tenure — see the full roster →
LabGenius funding rounds
At least $47.2M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $44.5M | 7 named | |
| SEC Form D filing | $2.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
LabGenius competitors
A few of LabGenius's closest competitors — see the full list of competitors and alternatives →
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Engine Biosciences is a Singapore-based biotechnology company and venture-creation platform that combines machine learning, computational biology, and laboratory experimentation to discover and develop new medicines. It builds and invests in therapeutic-focused biotech companies, serving pharmaceutical and healthcare markets.
Avicenna Biosciences, Inc. is a biotechnology company that uses machine learning-enhanced medicinal chemistry to accelerate drug discovery and optimization.
Biolojic Design is an Israeli biotechnology company that uses computational modeling and artificial intelligence to design and engineer antibodies and other therapeutic proteins. It develops drug candidates and collaborates with pharmaceutical and biotechnology companies seeking novel biologic medicines.
Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Get LabGenius's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on LabGenius in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access